Zürcher Nachrichten - Natural immunity more potent than vaccines during US Delta wave: study

EUR -
AED 4.35335
AFN 77.050797
ALL 96.614026
AMD 452.873985
ANG 2.121943
AOA 1087.00321
ARS 1723.800654
AUD 1.702936
AWG 2.136666
AZN 2.019869
BAM 1.955248
BBD 2.406031
BDT 145.978765
BGN 1.990709
BHD 0.449191
BIF 3539.115218
BMD 1.18539
BND 1.512879
BOB 8.254703
BRL 6.231008
BSD 1.194568
BTN 109.699013
BWP 15.630651
BYN 3.402439
BYR 23233.647084
BZD 2.402531
CAD 1.615035
CDF 2684.909135
CHF 0.915901
CLF 0.026011
CLP 1027.058063
CNY 8.240537
CNH 8.248946
COP 4354.94563
CRC 591.535401
CUC 1.18539
CUP 31.412839
CVE 110.234327
CZK 24.334287
DJF 212.720809
DKK 7.470097
DOP 74.383698
DZD 153.702477
EGP 55.903178
ERN 17.780852
ETB 185.572763
FJD 2.613371
FKP 0.863571
GBP 0.865754
GEL 3.194674
GGP 0.863571
GHS 12.974143
GIP 0.863571
GMD 86.533903
GNF 10372.164298
GTQ 9.16245
GYD 249.920458
HKD 9.257838
HNL 31.365884
HRK 7.536597
HTG 156.336498
HUF 381.328619
IDR 19883.141804
ILS 3.663335
IMP 0.863571
INR 108.679593
IQD 1553.453801
IRR 49934.560565
ISK 144.985527
JEP 0.863571
JMD 187.197911
JOD 0.840489
JPY 183.433247
KES 152.915746
KGS 103.662825
KHR 4768.236408
KMF 491.93733
KPW 1066.928941
KRW 1719.752641
KWD 0.36382
KYD 0.995519
KZT 600.800289
LAK 25485.888797
LBP 101410.128375
LKR 369.427204
LRD 219.593979
LSL 19.132649
LTL 3.500149
LVL 0.717031
LYD 7.495914
MAD 10.835985
MDL 20.092409
MGA 5260.173275
MKD 61.631889
MMK 2489.287708
MNT 4228.659246
MOP 9.606327
MRU 47.30937
MUR 53.852723
MVR 18.32658
MWK 2059.023112
MXN 20.70407
MYR 4.672854
MZN 75.580924
NAD 18.967522
NGN 1643.520192
NIO 43.508231
NOK 11.437875
NPR 175.519161
NZD 1.96876
OMR 0.458133
PAB 1.194573
PEN 3.994177
PGK 5.066955
PHP 69.837307
PKR 331.998194
PLN 4.215189
PYG 8001.773454
QAR 4.316051
RON 5.097064
RSD 117.111851
RUB 90.544129
RWF 1742.915022
SAR 4.446506
SBD 9.544303
SCR 17.200951
SDG 713.016537
SEK 10.580086
SGD 1.505332
SHP 0.88935
SLE 28.834661
SLL 24857.038036
SOS 677.454816
SRD 45.104693
STD 24535.182964
STN 24.493185
SVC 10.452048
SYP 13109.911225
SZL 19.132635
THB 37.411351
TJS 11.151397
TMT 4.148866
TND 3.37248
TOP 2.854135
TRY 51.47818
TTD 8.110743
TWD 37.456003
TZS 3052.380052
UAH 51.199753
UGX 4270.811618
USD 1.18539
UYU 46.357101
UZS 14603.874776
VES 410.075543
VND 30749.020682
VUV 141.680176
WST 3.213481
XAF 655.774526
XAG 0.014004
XAU 0.000244
XCD 3.203577
XCG 2.153028
XDR 0.815573
XOF 655.774526
XPF 119.331742
YER 282.508153
ZAR 19.136335
ZMK 10669.938133
ZMW 23.443477
ZWL 381.695147
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    1.3800

    83.78

    +1.65%

  • BTI

    0.4600

    60.68

    +0.76%

  • CMSD

    -0.0400

    24.05

    -0.17%

  • RIO

    -4.1000

    91.03

    -4.5%

  • AZN

    0.1800

    92.77

    +0.19%

  • GSK

    0.9400

    51.6

    +1.82%

  • CMSC

    0.0500

    23.76

    +0.21%

  • BCE

    0.3700

    25.86

    +1.43%

  • RELX

    -0.3700

    35.8

    -1.03%

  • RYCEF

    -0.4300

    16

    -2.69%

  • VOD

    -0.0600

    14.65

    -0.41%

  • NGG

    0.2000

    85.27

    +0.23%

  • BCC

    0.5100

    80.81

    +0.63%

  • BP

    -0.1600

    37.88

    -0.42%

  • JRI

    0.1400

    13.08

    +1.07%

Natural immunity more potent than vaccines during US Delta wave: study
Natural immunity more potent than vaccines during US Delta wave: study

Natural immunity more potent than vaccines during US Delta wave: study

During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.

Text size:

The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).

The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.

Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.

"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.

"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.

The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.

It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.

Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.

- Selection bias? -

By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.

In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.

Protection was highest among those who had both vaccination and prior Covid.

The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.

Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.

But the US CDC had previously taken the opposite position, based on pre-Delta data.

"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.

E.Schneyder--NZN